Healthcare -
Biotechnology - NASDAQ - US
$ 1.48
-10.8 %
$ 4.09 M
Market Cap
-0.11
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
--42.22%
EBIT
Estimate
90.96%
Net Income
Estimate
39.94%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Palisade Bio, Inc.
PALI has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart PALI
EBIT FORECAST
EBIT Forecast Chart PALI
NET INCOME FORECAST
Net Income Chart PALI